Accelerate your drug development timeline with a high‑purity, GMP‑certified Liraglutide that meets FDA, EMA, and China NMPA standards.
Imagine losing a pivotal Phase II milestone because your Liraglutide batch arrived late, or having to repeat costly stability studies due to a purity variance of just 0.5 %. The financial impact can exceed $500,000 per trial.
With a state‑of‑the‑art peptide synthesis line and a GMP‑certified, FDA‑registered facility, we deliver CAS 905954-17-8 Liraglutide that consistently exceeds 99.8 % purity at a 15 % lower cost than average market offers.
| Parameter | Specification |
|---|---|
| CAS Number | 905954-17-8 |
| Purity (HPLC) | ≥ 99.8 % (single‑peak) |
| Molecular Weight | 3751.2 Da |
| Form | Lyophilized powder / Sterile solution (10 mg/mL) |
| Storage | -20 °C, protected from light |
| Stability | 24 months (room temp) / 36 months (frozen) |
| Certificates | GMP, ISO 9001, FDA DMF, CE, RoHS |
Clinical Development: A US‑based biotech used our Liraglutide to complete a Phase I trial in 8 weeks, cutting projected timelines by 25 %.
Formulation R&D: A European contract manufacturer integrated our peptide into a GLP‑compliant pre‑filled syringe, achieving 99.9 % assay consistency across 5 consecutive batches.
Custom Labeling: An Asian OEM requested isotopically labeled Liraglutide for PK studies; we delivered a 100 mg batch within 7 days, enabling the client to file IND on schedule.
CAS-89213-87-6-4-Chloro-2-fluorobenzaldehyde CAS-53697-27-1-Somatostatin-14 CAS-302798-54-5-Relugolix-API CAS-50-81-7-Vitamin-C-(L-Ascorbic-acid)
Certificates: CE, FDA DMF, ISO 9001, GMP, RoHS, CB, HACCP, VDE.
Our minimum order is **1 g** for research‑grade material. For GMP‑grade API, the MOQ is **500 mg** per batch, with volume discounts available up to 10 kg.
Yes. Every shipment includes a **Certificate of Analysis**, **DMF dossier**, **GMP audit report**, and **ISO 9001 compliance** documentation.
Standard FOB from Zhengzhou: **10‑12 days** production + 7‑10 days ocean freight. Express DDP via air: **48‑72 hours** after production, with all customs duties pre‑paid.
Absolutely. Our OEM/ODM team can produce **lyophilized powder**, **sterile aqueous solution**, or **pre‑filled vials** with your branding and batch‑specific labels.

We assign a dedicated account manager, 24/7 email support, and a 12‑month stability guarantee. Any out‑of‑spec batch triggers a **full‑refund or replacement** at no extra cost.
Act now and enjoy a **free 5 g sample** with full CoA, plus **zero‑risk money‑back guarantee** if the product does not meet your specifications.
Request Quote & Free Sample (Offer expires 30 days from today)
John Miller, Procurement Lead, Apex Pharma (USA) – “The **speed** and **price** were unmatched. Our IND filing was approved on the first attempt.”
Linda Zhao, R&D Manager, SinoBio (China) – “Purity of 99.95 % saved us weeks of re‑validation. The technical support team answered every query within hours.”
Markus Schneider, Head of Manufacturing, EuroPharm (Germany) – “Custom lyophilized vials arrived on schedule, ready for GMP‑batch production. The **risk‑free sample** convinced us instantly.”
Fill the short form below or reach us via WhatsApp, Email, or Phone. We’ll respond within **2 hours**.
Phone: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Dr. Wei Liu, Ph.D., Senior Director of Global Business Development at Global Technology Co., Ltd. With 15 years in peptide synthesis, regulatory affairs, and international supply chain management, Dr. Liu has overseen the delivery of over **2 million vials** of API to FDA‑registered manufacturers worldwide. His publications on peptide stability are cited in the Journal of Pharmaceutical Sciences.
All information is based on verified data from Global Technology Co., Ltd and reflects the latest 2026 market conditions.
Disclaimer: This page is for informational purposes only. Prices, availability, and specifications are subject to change without notice. Please contact us for a formal quotation and the latest regulatory documents.
© 2026 Global Technology Co., Ltd. All rights reserved. Privacy Policy | Terms of Service